Godsey & Gibb Associates Pfizer Inc Transaction History

Godsey & Gibb Associates

$967 Million
Q2 2024

A detailed history of Godsey & Gibb Associates transactions in Pfizer Inc stock. As of the latest transaction made, Godsey & Gibb Associates holds 2,163 shares of PFE stock, worth $64,154. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,163

Previous 1,346 60.7%

Holding current value

$64,154

Previous $37,000 62.16%

% of portfolio

0.01%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	BUY	$25.26 - $29.6 $20,637 - $24,183	817 Added 60.7%	2,163 $60,000
Q1 2024 Apr 23, 2024	SELL	$25.89 - $29.73 $18,148 - $20,840	-701 Reduced 34.25%	1,346 $37,000
Q4 2023 Jan 16, 2024	BUY	$26.13 - $33.94 $26,548 - $34,483	1,016 Added 98.55%	2,047 $58,000
Q3 2023 Oct 25, 2023	SELL	$32.09 - $37.51 $34,240 - $40,023	-1,067 Reduced 50.86%	1,031 $34,000
Q2 2023 Jul 25, 2023	BUY	$36.12 - $41.79 $4,334 - $5,014	120 Added 6.07%	2,098 $76,000
Q1 2023 Apr 18, 2023	BUY	$39.39 - $51.28 $77,913 - $101,431	1,978 New	1,978 $80,000
Q3 2022 Oct 24, 2022	BUY	$43.76 - $53.42 $106,249 - $129,703	2,428 New	2,428 $106,000
Q2 2021 Aug 05, 2021	SELL	$35.91 - $40.68 $205,800 - $233,137	-5,731 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $191,931 - $216,459	5,731 New	5,731 $208,000
Q1 2021 May 13, 2021	SELL	$33.49 - $37.77 $314,906 - $355,151	-9,403 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $314,718 - $400,191	9,403 New	9,403 $346,000
Q1 2020 May 11, 2020	SELL	$27.03 - $38.62 $9.64 Million - $13.8 Million	-356,654 Closed	0 $0
Q4 2019 Feb 06, 2020	SELL	$32.92 - $37.36 $40,656 - $46,139	-1,235 Reduced 0.35%	356,654 $14 Million
Q3 2019 Nov 13, 2019	SELL	$32.49 - $42.13 $116,606 - $151,204	-3,589 Reduced 0.99%	357,889 $12.9 Million
Q2 2019 Aug 07, 2019	BUY	$36.98 - $41.52 $165,448 - $185,760	4,474 Added 1.25%	361,478 $15.7 Million
Q1 2019 May 14, 2019	BUY	$37.5 - $41.2 $293,062 - $321,978	7,815 Added 2.24%	357,004 $15.2 Million
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $147,647 - $168,334	-3,838 Reduced 1.09%	349,189 $15.2 Million
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $101,548 - $123,172	2,946 Added 0.84%	353,027 $15.6 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $1.6 Million - $1.7 Million	-48,363 Reduced 12.14%	350,081 $12.7 Million
Q1 2018 May 11, 2018	BUY	$31.91 - $37.02 $234,729 - $272,319	7,356 Added 1.88%	398,444 $14.1 Million
Q4 2017 Jan 23, 2018	SELL	$33.26 - $35.29 $404,308 - $428,985	-12,156 Reduced 3.01%	391,088 $14.2 Million
Q3 2017 Nov 03, 2017	SELL	$31.0 - $34.15 $966,828 - $1.07 Million	-31,188 Reduced 7.18%	403,244 $14.4 Million
Q2 2017 Aug 11, 2017	BUY	N/A	434,432	434,432 $14.6 Million

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Godsey & Gibb Associates, based on Form 13F filings with the SEC.

News

Stay updated on Godsey & Gibb Associates with notifications on news.

Account

Godsey & Gibb Associates Pfizer Inc Transaction History